Thomsen, Troels

Cardiovascular risk estimation in older persons: SCORE O.P

Cooney, M. T., Selmer, R., Lindman, A., Tverdal, A., Menotti, A., Thomsen, T., DeBacker, G., De Bacquer, D., Tell, G. S., Njolstad, I., et al. (2016) · European Journal of Preventive Cardiology

Health Promotion and Cardiovascular PreventionLipoproteins and Cardiovascular Health

Cited by 172

A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD(R) and the Copenhagen Risk Score

Thomsen, T. F., Davidsen, M., Ibsen, H., Jorgensen, T., Jensen, G., & Borch-Johnsen, K. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation

Health Promotion and Cardiovascular PreventionLipoproteins and Cardiovascular Health

Cited by 127

How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators

Cooney, M. T., Dudina, A., De Bacquer, D., Fitzgerald, A., Conroy, R., Sans, S., Menotti, A., De Backer, G., Jousilahti, P., Keil, U., et al. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 121

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial.

Falchi, L., Nijland, M., Huang, H., Linton, K. M., Seymour, J. F., Tao, R., Kwiatek, M., Costa, A., Vassilakopoulos, T. P., Greil, R., et al. (2026) · The Lancet

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 41